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wound care in the geriatric client
Abstract: With our aging population, chronic diseases that compromise skin integrity such as 
diabetes, peripheral vascular disease (venous hypertension, arterial insufficiency) are becoming 
increasingly common. Skin breakdown with ulcer and chronic wound formation is a frequent 
consequence of these diseases. Types of ulcers include pressure ulcers, vascular ulcers (arterial 
and venous hypertension), and neuropathic ulcers. Treatment of these ulcers involves recogniz-
ing the four stages of healing: coagulation, inflammation, proliferation, and maturation. Chronic 
wounds are frequently stalled in the inflammatory stage. Moving past the inflammation stage 
requires considering the bacterial burden, necrotic tissue, and moisture balance of the wound 
being treated. Bacterial overgrowth or infection needs to be treated with topical or systemic 
agents. In most cases, necrotic tissue needs to be debrided and moisture balance needs to be 
addressed by wetting dry tissue and drying wet tissue. Special dressings have been developed 
to accomplish these tasks. They include films, hydrocolloids, hydrogel dressings, foams, hydro-
fibers, composite and alginate dressings.
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Introduction
The demographic reality in the United States and other developed countries is that 
the population is aging and the medical community must provide care for an ever-
increasing number of elderly individuals. As with other disease processes common in 
the geriatric population, the incidence of chronic ulcers related to diabetes, peripheral 
vascular disease, and mobility issues occurs with increasing frequency. The purpose 
of this article is to address the etiology, assessment, and treatment options for the 
most frequently encountered types of chronic skin breakdown. Although the original 
goal may be complete wound healing, palliation and achieving a manageable, chronic 
wound may be an acceptable outcome.
Approximately 70% of all pressure ulcers occur in the geriatric population. Their 
skin has a decrease in water content, tensile strength, and junctional integrity between 
the dermis and the epidermis. Atrophy of the apocrine and sebaceous glands causes 
drying of the skin. A loss of subcutaneous tissue, vascularity, and diminishing stability 
of small blood vessels add other factors to compromise skin integrity.1–3
The most common wounds to be discussed are pressure ulcers (decubitus ulcers or 
bedsores), vascular ulcers (arterial and venous), and neuropathic ulcers. Assessment 
tools and techniques, appropriate classification systems, dressing choices, and treat-
ment modalities will be addressed. A brief discussion of some wound care products 
as they relate to chronic wound care will be presented.
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Types of chronic wounds
Pressure ulcers
Pressure ulcers are, as their name implies, caused primarily 
by unrelieved pressure. They usually occur over bony promi-
nences such as the sacrum or the heel, but can occur on any 
part of the body subjected to pressure. The damage causing 
a pressure ulcer can occur in a matter of hours. Shear forces 
and friction may also contribute to the formation of pressure 
ulcers. Pressure ulcers are described as stages relating to 
the depth of tissue damage incurred. In February 2007, the 
National Pressure Ulcer Advisory Panel (NPUAP) released 
updated definitions of these stages in order to clarify mis-
conceptions and reduce confusion that had been a frequent 
complaint with the original definitions put forth by Shea.4
These stages are used to describe pressure ulcers only 
(Figure 1). Other wound classification systems include partial 
or full thickness wounds. Partial thickness wounds involve only 
the epidermis and dermis. Full thickness wounds involve deeper 
tissues and structures. Diabetic foot ulcers also have unique 
classification systems to be described later.
Pressure ulcer prevention
Prevention of pressure ulcers is of paramount importance, and 
begins with a complete history and physical to determine risk 
factors.8 However, not all pressure ulcers are avoidable. As 
noted by Langemo and Brown, skin, as other organ systems 
can also fail.3
Even with appropriate treatment, Stage IV ulcers may 
require surgical intervention such as surgical flaps, deep 
debridement or possibly amputation. Healing Stage IV ulcers 
may take years and, as with any wound that heals by scar 
formation, result in tissue that is only 40%–80% of the tensile 
strength of undamaged tissue. Development of a pressure 
ulcer has been implicated in increased mortality, although 
the causal relationship has not been established.1
Potential interventions for prevention of pressure ulcers 
include the repositioning, nutrition, moisturizing dry skin 
or by preventing damp skin by targeting fecal or urinary 
incontinence and the use of special support surfaces. Urinary 
and fecal incontinence place the skin at risk not only due to 
excessive moisture, but also because of the chemical proper-
ties of urine and feces.9–10
Specialized support surfaces redistribute pressure on the 
skin and subcutaneous tissue. Unrelieved pressure can impair 
circulation and lead to ulcer formation. Pressure redistributing 
surfaces can be static or dynamic. Dynamic support surfaces 
mechanically vary the pressure under the patient thus reducing 
the length of time a particular skin area is under pressure 
theoretically improving circulation. Example of dynamic 
support surfaces include alternating pressure mattresses, low air 
loss mattress replacement systems, and air fluidized mattresses. 
A dynamic surface is recommended when the patient cannot 
reposition themselves, be adequately repositioned without 
weight bearing on a pressure ulcer or if the patient fully com-
presses the static surface.8 Examples of static support surfaces 
are foam mattresses or static flotation (air cells, gel, fluid over-
lays that are placed on top of the mattress).8 Foam overlays are 
no longer used for pressure redistribution. They do not function 
well and may violate fire codes.
Repositioning or turning patients while in bed is one of 
the most important ways to prevent pressure ulcers although 
passive positioning alone has not been shown to decrease the 
incidence of ulcer formation.1 The accepted standard of care 
is to turn patients at least every two hours. Minimizing pres-
sure in the skin will help maintain circulation to areas that 
are at risk for breakdown. It is important to keep pressure off 
areas such as the heels that are at risk for breakdown. This 
can be accomplished both by turning patients from side to 
side while in bed and floating the heels above the mattress 
by placing pillows, etc under the legs.
Nutrition is thought to be important in ulcer prevention 
although there is not a strong body of supporting evidence. 
A study by Bourdel-Marchasson and colleagues studied 672 
critically ill inpatients older than 65 comparing a standard diet 
to a standard diet plus two oral nutritional supplements per 
day.11 Patients receiving a standard diet had a relative risk of 
1.57 when compared to a group receiving standard diet plus 
two nutritional supplements. Nutritional evaluation includes 
serum albumin and pre-albumin levels, although decreased 
levels may reflect production of inflammatory cytokines not 
actual nutritional status.1
Proper skin moisture is also important in preventing skin 
ulcers. Dry sacral skin is a known risk factor for develop-
ing pressure ulcers. Hence, moisturizing dry skin may help 
prevent pressure ulcers. Massaging areas at risk over bony 
prominences while applying moisturizing lotions or cream 
may increase the risk of breakdown.
Skin that is frequently too wet by contact with urine or 
perspiration is at greater risk for breakdown. Improvement in 
continence care with interventions such as toileting patients 
every two hours, use of skin protectant barrier creams, etc., 
help maintain skin health.10
vascular ulcers
Vascular ulcers result from deficits in either quality of arterial 
flow or derangement of the venous system. The prevalence of Clinical Interventions in Aging 2009:4 271
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Stage I
Nonblanchable erythema of intact skin that 
does not resolve with 30 minutes of complete 
pressure relief 
Darkly pigmented skin lesions may present as 
darkening of the damaged tissue or may differ 
in texture, temperature or consistency from the 
surrounding tissue. 
Area at risk is sometimes identified as a 
“heralding lesion” it indicates potential for 
increased damage if not addressed 
immediately.
5–6
Deep tissue injury 
• New category added to the pressure ulcer 
staging system called deep tissue injury (DTI). 
• Nonblanchable purple or maroon discoloration 
of intact skin that may indicate damage to the 
underlying tissue. 
• DTI can heal or progress to a deep ulcer in a 
short period of time even with optimal and 
aggressive treatment. 
• Evaluation initially may be confusing if the 
hyperpigmented or bruised area is a result of 
DTI. One should err on the side of caution and 
identify the lesion as a suspected DTI.
5–7 
•
•
•
STAGE 1
SUSPECTED
DEEP TISSUE INJURY
Stage II  
•  Ulcers involve the epidermis and dermis only. 
(Partial thickness) 
•  Ulcer presentation may be as a serum-filled 
blister or a shallow, superficial ulcer with a pink 
or red wound base.  
•  Lesions may be painful.  
•  Slough, eschar or bruising are not present at 
this level.
5–6
STAGE 2
Figure 1 Pressure ulcer staging. Images are reused with permission from the National Pressure Advisory Panel. Copyright © 2009. http://ww.npuap.org/.Clinical Interventions in Aging 2009:4 272
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Figure 1 Continued
Stage III  
• Ulcers are full thickness; however tissue 
damage does not expose tendon, bone or joint 
capsule.  
•  Anatomical location and the depth or 
composition of the underlying tissue determine 
whether the ulcer is relatively shallow or deep. 
Areas that have no subcutaneous tissue may 
be relatively shallow, but areas with a thick 
cushion of adipose tissue may be deep but 
bone is not exposed or directly palpable.  
•  Undermining or tunneling may be seen with 
these lesions.
•  Undermining is tissue destruction extending 
under the skin along the perimeter of the 
wound with a relatively wide opening.  
•  Tunneling, on the other hand, has a relatively 
small opening, but the tissue loss may extend 
deeply into the adjacent tissue. 
5–6
STAGE 3
Stage IV
•  Pressure ulcer may extend into muscle, and in 
some cases, erode bone, tendons, ligaments 
and other supporting structures.  
•  Ulcer may have slough or eschar in portions of 
the wound bed and undermining and/or 
tunneling is common.  
•  Anatomical location dictates the depth of the 
wound, but the hallmark is the exposure of 
deeper supporting structures.
5–6
Unstageable 
•  Ulcers covered with slough, eschar or necrotic 
debris to the extent that the wound base is not 
visualized are classified as unstageable.  
•  Slough is soft nonviable tissue that may be 
yellow, gray, tan or green. Eschar is 
desiccated necrotic tissue and may be black, 
gray or brown.
5–6
•  Presence of slough or eschar indicates that 
the ulcer is at least Stage III because these 
tissues arise from subcutaneous fat or 
devitalized muscle.  
STAGE 4
UNSTAGEABLEClinical Interventions in Aging 2009:4 273
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peripheral arterial and peripheral venous disease is increased 
in the geriatric population. Evaluation must include both sys-
tems because these problems are not mutually exclusive.
Arterial ulcers
Arterial ulcers are a result of restriction of flow or occlusion 
of an artery. They have a discrete “punched out” appear-
ance, a pale wound bed and minimal exudate. Gangrene or 
necrotic tissue is common. Due to the ischemia underlying 
the development of these ulcers, they are often very painful 
and difficult to treat or heal.12 The most frequent locations 
for these ulcers are the tips of or between the toes, over the 
phalangeal heads, or over the lateral malleolus. Even a bump 
or scrape can precipitate an ulceration.13
If an arterial or ischemic ulcer is suspected, then the site 
should be evaluated for adequate blood flow. For leg and foot 
ulcers if there is a palpable dorsalis pedis pulse, the ankle sys-
tolic pressure is at least 80 mm Hg or higher and the brachial 
systolic pressure at least 100 mm Hg. These values are usually 
indicative of enough pressure to heal a wound. If a pulse is 
nonpalpable then evaluation of blood flow by Doppler ultra-
sound is important. The Ankle Brachial Index (ABI) is used 
to determine quality of blood flow and ascertain if a wound 
is healable.16 The ABI is calculated by dividing the dorsalis 
pedis systolic pressure by the brachial artery systolic pressure. 
A value less than 0.5 (moderately severe ischemia) means that 
it will be difficult for the wound to heal.16 If the ABI is greater 
than 1.2 (especially in the diabetic or renal failure patient) it may 
mean that the vessels are heavily calcified, which can produce 
a falsely elevated ABI. Toe pressures can then be used because 
the vessels supplying the toes do not have calcium deposits. Toe 
pressures greater than 50 mm Hg are normal; whereas values 
of less than 30 are grossly abnormal. Frequently, wounds can 
heal with toe pressure values between 30–50 mm Hg.17
The treatment of arterial ulcers is based on optimization 
or restoration of adequate perfusion and may be achieved by 
risk factor modification, activity and positioning, medication 
or surgical treatment.13 Risk factor modification includes 
smoking cessation, controlling diabetes, hypertension, and 
hyperlipidemia. A daily walking program is encouraged. Leg 
elevation is relatively contraindicated in patients with arterial 
ulcers. Patients with arterial ulcers should wear compression 
bandages or stockings only with careful consideration of the 
risks and benefits and with close monitoring.
Two drugs are approved by the Federal Drug Admin-
istration (FDA) for promoting blood flow in patients with 
arterial ulcers or claudication: pentoxyphilline (Trental), and 
cilostazol (Pletal). These medications are phosphodiesterase 
inhibitors that prevent platelet aggregation. Trental improves 
erythrocyte and leukocyte flexibility and thins the blood. 
Pletal also increases vasodilatation. However, its use is 
contraindicated in patients with congestive heart failure.14
Surgical treatment is recommended for patients with rest 
claudication who are at risk for limb loss.13 The site of arte-
rial occlusion can partially be determined by the location of 
pain or fatigue. Occlusion of the aorta or iliac arteries causes 
symptoms in the buttocks or hips, femoropopliteal disease 
causes symptoms in the calf.15 Bypass grafting, stent place-
ment, or angioplasty are possible options for intervention.
venous ulcers
Venous ulcers are caused by venous hypertension resulting 
in uncontrolled edema. Venous hypertension may result from 
a deep vein thrombosis (DVT) or postphlebitic syndrome, 
obesity, congestive heart failure or severe trauma to the leg. The 
visible changes in the tissue of the leg associated with venous 
hypertension are: hemosiderin staining, the hyperpigmentation 
resulting from red blood cells leaking into the tissue and deposi-
tion of the heme; stasis dermatitis marked by erythema, edema, 
scaling, and weeping of serous fluid; lichenification, thickening 
of the tissue; and skin ulceration.12,18 Long-term untreated or 
under-treated venous hypertension, may result in development 
of lymphedema, which further complicates treatment.
Venous ulcers are generally shallow with irregular wound 
margins. The ulcer base tends to be beefy red and granulation 
is frequent with exudates most often moderate to heavy. If 
there is an arterial component, the color and amount of exu-
dates may be muted. These wounds may have a strong odor 
that may be concerning to the patient and must be addressed 
when providing wound care. Venous ulcers are classically 
located over the medial malleolus although sometimes they 
can be near the lateral malleolus. In severe cases they may 
encircle the entire ankle.19 Other disease processes such as 
vasculitis, pyoderma gangrenosum, or neoplasms may be 
mistaken for venous ulcers. Ulcers that do not respond to 
standard treatment should be referred for further evaluation, 
ie, dermatology, vascular or plastic surgery, etc.
The treatment of venous ulcers includes specific recom-
mendations regarding activity, positioning and compression 
therapy. Standing or sitting with the legs in a dependent posi-
tion should be discouraged. Patients should shift their weight 
frequently when standing and should be encouraged to have 
a daily walking program. Leg elevation above the level of 
the heart is recommended to reduce edema. Compression 
therapy is essential to venous ulcer healing and prevention of 
recurrence. Before compression therapy can be used arterial Clinical Interventions in Aging 2009:4 274
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status should be evaluated and deemed to be adequate. ABIs of 
0.5 or greater are required to initiate compression therapy. 
Many types of compression devices are available that provide 
sustained graduated compression at a therapeutic level. These 
include elasticized tubular support bandages, elastic wraps, 
custom fitted compression stockings and wraps with hook and 
loop closure such as CircAids.20 The Unna boot is an example 
of rigid compression therapy that goes on wet but dries to 
becomes rigid, it works through enhancement of the calf muscle 
pump and is appropriate for ambulatory patients.20 There are 
several multi-layer elastic compression systems available that 
provide moist wound healing, wound protection, absorption of 
drainage and continuous therapeutic levels of compression.18 
Careful consideration of requirements for use of these devices 
as outlined in the manufacturers guidelines is warranted.
Neuropathic ulcers
Neuropathy is most often associated with diabetes, but may 
result from other diseases. Neuropathy falls into three cat-
egories: sensory, motor, and autonomic. The most common 
is sensory neuropathy resulting in an insensate foot. Ulcer 
causality is multifactorial, the presence of sensory neuropa-
thy, peripheral occlusive vascular disease and the presence 
of bony deformities increase the incidence of foot ulcers.21 
Diabetic foot ulcers may be classified in stages according 
to the natural history progression: 1) normal foot; 2) high 
risk foot; 3) ulcerated foot; 4) infected foot; 5) necrotic 
foot.22 Patients with loss of protective sensation have been 
shown to have a 15 fold increase in the risk of developing 
a foot ulcer.23 When the protective sensory threshold is 
lost, patients may continue to experience tissue damaging 
pressure or trauma. The ulcers are typically located in areas 
exposed to repetitive pressure and the precursor of callus or 
blister formation can alert patients and providers alike to an 
impending ulcer. Callus formation is a normal response to the 
stress of elevated pressures on an area of the foot. The callus 
can act like a stone (local pressure) in the shoe.24 Repetitive 
pressure can lead to formation of an ulcer at the site of the 
callus. Ulcers can occur undetected under a callus and only 
declare themselves with an infection that threatens the foot 
or lower limb. Testing for protective sensory threshold is 
done with a Semmes–Weinstein 5.07/10 gm monofilament 
(Semmes–Weinstein Corp., NY, USA).24
Motor neuropathy causes an imbalance in the forces 
of flexor versus extensor muscles, with the stronger flexor 
muscles generally overpowering the extensors causing 
deformities such as hammer toes, claw toes, etc. These 
deformities change the configuration of the protective pads 
of the foot leaving the joints in jeopardy for breakdown. As 
the toes contract the patient walks on the tips of the toes 
instead of the plantar surface, the phalangeal heads become 
more prominent and subject to pressures from the shoes. 
The protective pads over the metatarsal heads are also pulled 
forward leaving the tissue over them at high risk for develop-
ment of pressure ulcers.
Autonomic neuropathy causes a decrease in sweating 
leading to excessively dry skin. This can cause the skin to 
dry and thicken, often resulting in painful fissures that are a 
potential portal for infection.25 Loss of autonomic regulation 
allows dilatation of the blood vessels of the foot, demineral-
ization, and softening of the bones leading to Charcot foot 
deformities.25
Prevention of diabetic neuropathic foot ulcers is para-
mount; 60% of nontraumatic lower-limb amputations are 
diabetes-related.26 People with diabetes should wear com-
fortable well fitting shoes and never walk barefoot. Glucose 
control needs to be optimized to help prevent neuropathy 
and aid in healing. Calluses or corns should be treated by 
a professional. Patients providing self-care must follow 
their professional’s guidelines and instructions carefully. 
Off-loading pressure on the ulcer is necessary using devices 
such as wheelchairs, crutches, walkers, total contact casts, 
total contact sandals, short leg walkers and wedged heal-
ing shoes.19 If adequate blood flow is present, periwound 
hyperkeratosis needs to be debrided with the wound margin 
being “saucerized” (debrided so wound margins slope like 
a shallow bowl, thereby reducing pressure and optimizing 
wound healing). Surgical correction of a specific foot defor-
mity may be required.23
Other modalities are being used for treatment of non-
healing diabetic foot ulcers including negative pressure 
wound therapy, recombinant human growth factors and skin 
substitutes. The US FDA has issued an ongoing safety review 
regarding becaplermin (Regranex), a topical recombinant 
form of human platelet-derived growth factor: “… there may 
be some evidence for an increased risk of death from cancer 
in patients who had repeated treatment with Regranex.”27 The 
risk of a nonhealing diabetic foot ulcer should be weighed 
against the possible risk of using Regranex on an individual 
basis.27
Stages of healing
There are four major stages of healing of acute wounds. 
They include coagulation, inflammation, proliferation and 
maturation. During coagulation platelets start healing by 
releasing mediators such as growth factors. In inflammation, Clinical Interventions in Aging 2009:4 275
wound care in the geriatric client Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
there is vasodilatation, an increase in capillary permeability, 
complement activation and migration of neutrophils and 
macrophages to the site. The neutrophils and macrophages 
destroy bacteria, release proteases, and secrete growth fac-
tors. Inflammation is regulated by bacteria and cytokines.
Cell proliferation occurs when fibroblasts, endothelial 
cells, and keratinocytes promote cell migration, proliferation, 
angiogenesis and synthesis of extracellular matrix compo-
nents. Remodeling or maturation occurs over several weeks 
to months after a new scar is formed and collagen fibers are 
rearranged into a more orderly configuration modifying the 
appearance of the scar tissue.28
Unfortunately chronic wounds become stalled in the 
inflammation stage and do not progress to the proliferation 
stage. Chronic wounds have an increase in proinflammatory 
cytokines. They also have an increase in matrix metallopro-
teinases (MMPs). MMPs are a family of zinc-dependent 
endopeptidases secreted as inactive zymogens. They are 
capable of degrading most extracellular components and 
basement membrane proteins at a neutral Ph. Within the skin 
they are produced by keratinocytes, fibroblasts, neutrophils, 
macrophages, mast cells and eosinophils. This proinflamma-
tory environment contains many proteins that break down the 
developing collagen matrix and impede healing.29 Products 
such as Promogran (Johnson and Johnson Wound Manage-
ment, Somerville, NJ, USA), BioStep or BioStep Ag (Smith 
and Nephew, London, UK) are collagen matrix dressings that 
also contain other components. Placed in the wound base it 
may prevent the breakdown of growth factors and reduce 
the effect of MMPs.30
Major considerations in treating  
a chronic wound
Bacterial balance, necrotic tissue, and moisture balance 
comprise the three major considerations in treating a chronic 
wound. These areas must be addressed in order for healing 
to occur.
Bacterial balance
All wounds contain some bacteria. The question is whether 
the amount of bacteria merely represents colonization of the 
wound or represents bacterial overgrowth and infection. The 
latter can lead to impaired wound healing.28
There are many signs and symptoms which suggest bacte-
rial over growth and infection. Either a subclinical or overt 
infection may prevent wound healing. Signs and symptoms 
include change in wound exudate that may be clear or serous 
then become purulent in appearance, an unpleasant odor from 
the wound can indicate superficial or deep infection. Bacterial 
stimulation of vascular endothelial growth factor (VEGF) 
can occur which stimulates new blood vessel formation and 
hence makes the area more likely to bleed. An increase in 
cutaneous temperature and increased surrounding erythema 
suggests an infection.28,31
Treatment of bacterial overgrowth and infection is 
determined by whether the infection is superficial or deep. 
Superficial bacterial overgrowth can be treated with topical 
agents. Deep tissue infections such as cellulitis, muscle, and 
bone (osteomyelitis) infections must be treated with systemic 
antibiotics and frequent debridement.16 Oral antibiotics 
may be used for less severe infections with intravenous 
(IV) antibiotics reserved for more severe infections such as 
advancing cellulitis or osteomyelitis. Antibiotics are deter-
mined by Gram stain and suspicion initially and adjusted 
based on bacterial identification with antibiotic sensitivity. 
The microbial flora of a chronic wound changes over time. 
In an early wound, Gram-positives such as Staphylococcus 
aureus and beta-hemolytic streptococci predominate. After 
four weeks, Gram-negative rods ie, Proteus, Escherichia coli 
and Klebsiella will colonize the wound. Later on anaerobes 
come into play and after several months the average wound 
may be colonized by 4–5 different organisms.28
Superficial bacterial overgrowth can usually be treated 
with topical agents, sometimes as simple as normal saline, 
which can keep a chronic wound clean. Wounds that have 
no chance of healing should also be treated with topical 
agents with the goal of preventing the nonhealing wound 
from becoming infected.
Examples of topical agents are chlorhexidine, betadine, 
acetic acid, hydrogen peroxide, scarlet red dye, and baci-
tracin. Chlorhexidine and betadine are broad spectrum and 
have low tissue toxicity. Acetic acid is effective against 
pseudomonas. Dyes are effective against Gram-positive 
cocci but not against Gram-negative bacteria.28 These agents 
should be used for cleansing dirty or infected wounds only 
and not for clean wounds as they may cause damage to the 
wound bed.16
Broad-spectrum antimicrobials such as silver products, 
polyhexamethylene biguanide, Cadoxemer Iodine or polyac-
rylates are beneficial in decreasing the bioburden of a chronic 
wound and are also used to treat superficial infections.16 
Silver-based agents are also used to treat superficial infection. 
There are a wide range of silver-based agents. Examples of 
such agents include: hydrogels, alginates, foams, negative 
pressure wound therapy foam dressings, and some compres-
sion garments. The controversy in the industry is whether the Clinical Interventions in Aging 2009:4 276
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total amount of silver or the chemically available amount is 
more important in bacterial control. Silver dressings should 
be chosen according to the amount of silver released and their 
relative moisture absorption and retentive properties.33
Dealing with necrotic tissue 
through debridement
Necrotic tissue impedes the healing of both acute and chronic 
wounds. It impairs the development of granulation tissue 
and impairs the migration of keratinocytes that are required 
for re-epithelialization.16,34 Necrotic tissue can also serve as 
a medium for bacterial overgrowth. Removing the necrotic 
tissue reduces the bacterial burden.16,17
Evaluation of a wound’s potential for healing is a prime 
consideration in treatment choices. Determining whether a 
wound can heal is accomplished by evaluating whether the 
wound has an adequate blood supply. Checking for pulses, 
capillary refill and Doppler pressures are ways to determine 
if a blood supply is adequate.16–17
Debridement of an ischemic wound increases tissue loss 
and the risk of infection and is therefore contraindicated. An 
example of this is dry gangrene of the toes. Debriding or 
increasing moisture in ischemic lesions may convert dry gan-
grene to wet gangrene and hasten a life threatening infection. 
If a wound has an adequate blood supply, then debridement 
of necrotic tissue should be considered. Several methods of 
debridement are available. Sharp or surgical debridement is 
removal of necrotic tissue with scissors or a scalpel blade 
and forceps. This can be performed in a clinic setting or at 
the bedside. If indicated, premedication of the patient with 
topical, oral or parenteral pain medication reduces patient 
discomfort and facilitates adequate debridement. Sharp sur-
gical debridement is the most rapid way to remove necrotic 
tissue and has been shown to be effective in treating diabet-
ics with neuropathic foot ulcers. It has also been shown to 
be effective in treating difficult to heal venous ulcers when 
compared to no debridement.17
Autolytic debridement occurs when the wound is covered 
with a dressing and the body’s own proteolytic enzymes 
released by macrophages act to liquefy necrotic tissue. 
Hydrogels, films and hydrocolloids are some of the dressing 
types that facilitate autolytic debridement (Table 1). Use of 
these dressing must be carefully considered in the presence 
of an incompetent immune system. Wounds must be carefully 
cleansed prior to application of a new dressing.17
The third method of debridement is with an enzymatic 
agent (EA). Collagenase remains the only EA still available 
in the United States. Dressings with EAs must be changed 
at least once a day. Wounds should be closely monitored, as 
the EA can sometimes damage healthy tissue at the margins 
of the dressing.17
Mechanical debridement is achieved by use of the clas-
sic wet-to-dry dressing and whirlpool or hydrotherapy. 
Wet-to-dry dressings involve packing a wound with saline-
moistened gauze and covered with a dry dressing. The dress-
ing is allowed to dry and is then quickly removed along with 
adherent tissue. Unfortunately, it is nonselective and can 
remove vital tissue as well as necrotic tissue, may be very 
painful and may prolong healing time. This dressing tech-
nique is never indicated for use in clean, granulated wounds. 
Whirlpool therapy uses the action of fast-moving water to 
remove necrotic tissue. This strategy is rarely used, as it has 
not been shown to be very effective and may increase lower 
extremity edema.17
Maggot therapy can also be used to debride some wounds. 
Sterilized greenbottle fly maggots are applied to the wound 
every 2–3 days. Maggots secrete enzymes into the wounds 
which act like proteases to degrade necrotic tissue. The 
larvae have the ability to digest bacteria and can help with 
heavily colonized wounds. Maggot therapy has been shown 
to decrease wound size.16,17,34
Moisture balance
In addition to bacterial burden and debridement of necrotic 
tissue, moisture balance must be considered when looking 
at the bed of a chronic wound. In the remote past it was 
considered best to have a dry wound to facilitate healing but 
more recent research has proven that healing is accelerated 
in a moist wound environment. A wound with too much 
moisture and drainage can damage surrounding tissue caus-
ing maceration.36
The components in the exudate of chronic wounds dif-
fer significantly from those of acute wounds. Acute wounds 
are rich in growth factors that help promote the generation 
of fibroblasts, epithelial cells and keratinocytes. In contrast, 
exudate in the chronic wound has higher concentrations of 
MMPs, proenzymes that tend to degrade the wound matrix 
that is optimal for wound healing. Hence for chronic wounds 
it is necessary to remove excessive exudate or moisture high 
in MMPs.36
The wound environment must maintain proper moisture 
balance. This can be done by increasing moisture to wounds 
that are too dry and decreasing the moisture of wounds that 
are too wet. Some of the newer generation of wound dress-
ings are designed to do this. Research continues to work 
toward the development of the “ideal dressing” that can Clinical Interventions in Aging 2009:4 277
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address the major concerns in wound care. In 1979, Turner 
described the ideal dressing as possessing the following 
characteristics:
•  Removes excess exudates and toxins
•  Provides high humidity at the dressing wound interface
•  Allows for gaseous exchange
•  Provides thermal insulation
•  Protects against secondary infection
•  Remains free from particulate and toxic components
•  Causes no trauma on removal.37
These characteristics are still pertinent today. Some of the 
many types of wound dressings will be discussed below.
Table 1 examples of dressing types
Trade name Manufacturer
Films
Tegaderm 3M
OpSite Smith and Nephew
Bioclusive Johnson and Johnson
Transparent film dressing Invacare
Polyskin II Transparent Kendall
Hydrocolloids
Tegaderm Hydrocolloid Dressing 3M
Cutinova Smith and Nephew
replicare Hydrocolloid Dressing Smith and Nephew
CombiDerM ACD Cover Dressing ConvaTec
Duoderm CGF Control Gel Dressing ConvaTec
Comfeel Plus Clear Dressing Coloplast
restore extra Thin Hollister
restore Hydrocolloid Dressing Hollister
Hydrogel
CUrAGeL Kendall
Curasol Gel wound Dressing Healthpoint
DuoDerM Hydroactive Gel ConvaTec
Normigel 0.9% Isotonic Saline Gel Molnlyke
NU-GeL wound Dressing Johnson and Johnson
restore Hydrogel Dressing Hollister
Tegaderm Hydrogel Dressing 3M
Alginate
AlgiSite M Calcium Alginate Dressing Smith and Nephew
CUrASOrB Kendall
Calcium Alginate wound Dressing Invacare
KALTOSTAT ConvaTec
NUDerM Dressing Johnson and Johnson
restore Calcium Alginate Dressing Hollister
restore Silver Calcium Alginate Dressing Hollister
Sorbsan wound Dressing UDL Laboratories
Foam
Tegaderm Foam Adhesive 3M
Allevyn Smith and Nephew
Biatain Adhesive Foam Dressing Coloplast
COPA Hydrophilic Foam Dressing Kendall
Invacare Polyurethane Foam Dressing Invacare
Lyofoam ConvaTec
Mepilex MolnlykeClinical Interventions in Aging 2009:4 278
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Treatments or dressings 
that increase moisture
Transparent films
Film dressings exist in either adhesive or non-adhesive 
forms. They are made of either polyurethane or synthetic 
polymer sheets. They are frequently used to cover IV cath-
eter sites and are sometimes used to help protect or heal 
partial thickness wounds. They have no ability to absorb 
excess moisture and cannot be used as a primary dress-
ing for exudating wounds. They are best used for treating 
superficial, nonexudative wounds or during the late stages 
of wound healing.38 Combined with cross-hatching of eschar 
(cutting through the thick, dry tissue in a grid pattern) with 
a scalpel, covering the wound with a transparent film can 
quicken debridement.28
Hydrocolloids
Hydrocolloids have an inner hydrocolloid gelling agent 
that is made of carboxymethylcellulose (CMC) com-
bined with pectin. This is sandwiched between an inner 
adhesive layer that rests on the wound surface and an 
outer coating of foam or a film.36 The hydrocolloid gel 
absorbs moisture when exposed to the wound exudate 
and forms a gel. As hydrocolloids absorb more moisture, 
they become more water permeable. This allows them to 
transmit moisture and manage wound exudate. Due to 
their hydrating properties with the mixture of the patient’s 
own endogenous enzymes, hydrogel dressings are useful 
in autolytic debridement of the wound bed.36 When the 
dressings are removed they may leave some of the gelling 
agent behind which can have a foul odor and be confused 
with infection, therefore it is imperative to cleanse and 
assess the wound after removal of the dressing. These 
should be changed every 2–7 days as needed, indicated 
either by leaking of exudate, loosening or displacement 
of the dressing.
Hydrocolloids are useful in treating venous ulcers, 
pressure ulcers and (if used judiciously) diabetic foot ulcers.36 
They are relatively contraindicated with treating arterial 
insufficiency, vasculitis, and infection.34
Hydrogel dressings
Hydrogel sheet dressings are semi-occlusive and composed 
of a cross linked network of hydrophilic polymers.36 Semi-
occlusive dressings enhance autolytic debridement of dry to 
mildly exudative wounds. They are useful in burn patients 
because they have a soothing effect, but should not be 
used in ischemic ulcers. All hydrogel sheets are somewhat 
transparent and allow monitoring of the wound without 
removing the dressing. They should be changed every 24 to 
72 hours. Wound treatment gels are either isotonic or hyper-
tonic depending on whether the intent is to maintain a moist 
wound environment or to enhance debridement and are used 
with a secondary dressing.
Treatment or dressings  
that reduce moisture
Calcium alginate dressings
Alginate dressings are made from kelp and consist of 
calcium alginate polysaccharides. They work through a 
sodium–calcium ion exchange between the wound exudate 
and the dressing. This produces a sodium–alginate gel 
with moisture retaining or absorbing properties making 
them useful for treating draining or infected wounds. 
The calcium ions released by these dressings also aid in 
the coagulation pathway. This type of dressing may be 
useful in bloody exudative wounds. Alginates high in 
mannuronic acid form a soft gel that partially dissolves 
in solutions containing sodium ions, such as wound 
exudate. Alginates with high concentrations of gulu-
ronic acid, retain their integrity and structure throughout 
the gelling process.39 When removed from the wound, 
these dressings frequently have an odor and may give 
the appearance of an infected wound. It is important to 
cleanse the wound before assessing for the presence of 
infection. Alginates are useful in wounds with moder-
ate to heavy exudates. The concomitant use of topical 
antibiotics or other antimicrobial agents may decrease 
absorption of fluids.41
Foam
Foam dressings have an absorbent porous hydrocellular 
polyurethane center which is laminated with a semi-occlusive 
outer layer.28 Foam dressings are configured with different 
outer layers that have varying moisture vapor transmission 
rates. Dressings that have higher moisture vapor transmission 
rate allow moisture to be transmitted through the dressing 
and evaporated. This property makes these dressings useful 
in highly exudative wounds.28
Foam dressings may be either adherent or nonadherent 
and come in a variety of shapes and absorbency. They have 
different degrees of flexibility and density and many can 
be shaped to fit wounds of any size and depth. The opacity 
of the dressing prevents inspection of the wound without 
removal.Clinical Interventions in Aging 2009:4 279
wound care in the geriatric client Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
Hydrofiber
Hydrofiber dressings are available in sheets or ropes. They 
are composed of highly absorbent sodium CMC. They are 
indicated for wounds that have moderate to heavy exudate. 
Because they are nonadherent, they require a secondary 
dressing to keep them in place. Hydrofiber dressings are 
useful in the treatment of draining chronic venous ulcers. 
Both foam and hydrofiber dressings have wear times of up 
to one week.28
Composite dressings
Composite dressings are comprised of multiple layers with 
varying absorbent properties. They are useful in exudate 
control and as a secondary dressing for foams, alginates, and 
hydrofibers. They can be used under a compression dressing 
alone or in combination with other dressings have a wear 
time of up to one week.29
Synthetic skin grafts
Synthetic skin grafts, also called skin substitutes, were 
developed to avoid the morbidity associated with full thick-
ness skin grafts and to decrease time required for wound 
healing.30,31 Several products (Alloderm, Integra Neurosci-
ences, Plainsboro, NJ, USA; Integra, Integra Life Sciences, 
Plainsboro, NJ, USA; Apligraf, Novartis, Basel, Switzerland; 
Dermagraft, Advanced BioHealing, LaJolla, CA, USA) are 
on the market and are bioengineered from cells derived from 
different sources.31 Synthetic skin grafts have been shown 
to increase the likelihood of healing of venous ulcers when 
compared to conventional dressings.31
Negative pressure wound therapy
Negative pressure wound therapy (NPWT) consists of apply-
ing a foam or gauze dressing over the surface of the wound. 
It is secured with a transparent film to form an airtight seal. 
Continuous or intermittent negative pressure is applied. 
Wound healing is accelerated by removing excess interstitial 
fluid, improving blood flow reducing bacterial count, stimu-
lating angiogenesis and increasing tissue perfusion.31,42
Conclusion
The aging population presents many challenges to the medical 
community in the provision of care; among them is wounds 
care. Although it is a complex subject, basic understanding 
of the healing process, the most common types of ulcers and 
some of the dressing options available is necessary in caring 
for these patients. A multidisciplinary approach maximizes 
wound care in the elderly by drawing on each team member’s 
expertise. The majority of elderly patients with ulcers heal if 
treated assertively and appropriately. Healing is not possible 
in many instances. A holistic approach to wound care is para-
mount. Symptom management, whether healing or palliation 
is the goal, will improve overall outcomes for the elderly 
patient. The reward of providing wound care is in assisting 
a person to an enhanced health-related quality of life.
Case studies
To illustrate the decision-making process that is involved 
in care related to specific types of wounds, consider the fol-
lowing case studies:
Case study DM:   venous stasis ulcers
Mr. DM was a morbidly obese, 66-year-old man when admit-
ted to the hospital with left lower extremity cellulitis and 
venous ulcers. Pertinent diagnoses: Type II diabetes mellitus, 
vitamin D deficiency, sleep apnea, history of congestive 
heart failure, hypertension and hyperlipidemia. Of note, his 
glycosylated hemoglobin (HbA1c) was 6.9, albumin was 
3.0 (normal 3.5–5.2) and his white blood cell (WBC) count 
11,600. Weight was 274.2 pounds (124.4 Kg), height 73 inches 
(160.6 cm), with a body mass index (BMI) of 36.25.
He was given furosemide 40 mg IV on day one, 40 mg 
IV bid day two, and another 40 mg IV on day three. He was 
also started on sulfamethoxazole 800/trimethoprim 180 DS 
bid. Profore 4-layer compression dressings were applied to 
bilateral lower extremities for 4+ interstitial edema. Follow-
up care in the wound clinic after discharge from the hospital 
involved debridement of crusting lesions and Unna boot 
wrap with compression. Within two weeks, the cellulitis had 
resolved and the edema was reduced.
Compression stockings (knee high 20–30 mm Hg) were 
obtained and donned. The following week, his cellulitis had 
exacerbated. Keflex and clindamycin were given with com-
plete resolution of the infection. He experienced continued 
edema with use of compression stockings so compression 
wraps were again initiated and he was measured for CircAids. 
When the CircAids were received, he was converted to these 
devices and did well. Edema was controlled and he has had 
no recurrence of ulcers (Figures 2 and 3).
Case study AL: Pressure ulcers
Mr. AL was a 67-year-old man admitted to the Nursing Home 
Care Unit because of adult failure to thrive, malnutrition, 
depression, and multiple pressure ulcers. He was s/p CVA 
with left hemi paresis and contractures of both upper and 
lower extremities. His weight was 105 pounds (47.6 Kg), Clinical Interventions in Aging 2009:4 280
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Figure 2 Anterior left lower leg, venous hypertension ulcer.
Figure 3 Posterior left lower leg, venous hypertension ulcer.Clinical Interventions in Aging 2009:4 281
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height 69 inches (151.8 cm), and BMI 15.54. On admission he 
had the following pressure ulcers (Figures 4–9; Table 2):
Initially, all lesions were cleansed with normal saline. 
Silver alginate was applied to wound bases of Stage III 
and IV ulcers, covered with composite absorbent dressings 
(ABDs) and secured with hypoallergenic tape. The silver 
alginate was intended to decrease bacterial load and absorb 
exudate and the composite dressings for exudate control. 
Nonadhering and composite dressings were applied to left 
foot and secured with roller gauze. The nonadhering dressing 
was to prevent the dressing from sticking to the wounds and 
the composite dressings for exudate control. A hydrocolloid 
dressing was applied to the right thigh ulcer to provide moist 
wound healing and a bacterial barrier. Pressure-relieving 
boots were ordered to enhance healing and prevent further 
damage to feet.
An aggressive plan consisting of a turning and positioning 
schedule, wound care nutritional support, physical therapy for 
positioning assistance and occupational therapy for contrac-
ture mobilization was instituted. He was placed on a low air 
loss mattress for pressure redistribution. He had a Foley cath-
eter to gravity drainage for urinary retention due to neurogenic 
bladder. Care was complicated by fecal incontinence.
Changes were made in the dressing procedures: Collage-
nase (Santyl) was applied daily to debride left hip ulcers and a 
composite dressing cover that was secured with hypoallergenic 
tape. A hydrocolloid dressing over silver alginate was applied to 
the left hip and coccyx lesions to prevent fecal contamination of 
wounds, control exudate and provide for moist wound healing. 
Double layer foam dressings were applied to the bilateral left 
ankle lesions which consisted of an intact dressing to cover the 
ulcer for exudate control and to protect the periwound skin, and 
second layer with hole in center to aid in pressure redistribution. 
These dressings were secured with roller gauze.
Mr. AL developed contact dermatitis from the foam 
dressings. Triamcinolone 0.1% and hydrophilic ointment 
were ordered and applied every day. The ulcers were healed, 
no dressings required, use of pressure reducing boots for left 
foot was continued. His rash resolved.
Case study wC: Diabetic foot ulcers
Mr WC was a 64-year old man status post cerebral vascular 
accidents × 5 with residual right hemiparesis and myocar-
dial infarction × 2. Other pertinent diagnoses include: Type 
II diabetes.
He developed bilateral posterior heel pressure ulcers and 
was initially seen in the Podiatry clinic where debridement 
was performed. Care was coordinated between the Wound 
Care Clinic, Podiatry and a Home Health Agency Registered 
Nurse.
The left heel ulcer (Stage III) was 50% yellow slough and 
50% granulation tissue. The lesion was cleansed with normal 
saline, a silver hydrogel was applied and a foam dressing with 
a moisture barrier as a secondary dressing and secured with 
roller gauze. The right heel ulcer was larger and probed to 
bone (Stage IV). The wound base was 50% yellow slough and 
50% granulation tissue. There was a border of hyperkeratotic 
tissue along the plantar surface. The lesion was cleansed with a 
solution of 5cc betadine solution in 500 cc saline and rinsed with 
normal saline (NS). Kovia ointment (an enzymatic debriding 
agent) was applied to slough, covered with a saline-moistened 
gauze and then a dry sterile dressing. Heel protective boots were 
obtained and donned bilaterally. The patient was provided with 
supplies for continued treatment by his home health nurse.
Table 2 Mr.   AL’s pressure ulcer 
  •  Left foot medial malleolus 2.4 cm × 2.2 cm Stage Iv
  •  Left medial midfoot 2.0 cm × 0.8 cm Stage II
  •  Left medial 1st met head 0.5 cm × 0.8 cm Stage II
  •  Left medial hallux 1.4 cm × 1.5 cm Stage III
  •  right hip 7.0 cm × 4.5 cm epithelialized
  •  Posterior right thigh 0.8 cm × 2.1 cm Stage III
  •  Coccyx 4.2 cm × 3.7 cm × 0.8 cm Stage Iv
  •  Left hip 3.0 cm × 3.5 cm × 1.2 cm Stage Iv
  •  Left hip, eschar 3.0 cm × 4.0 cm Unstageable
  •  Left lateral ankle 3.8 cm × 3.8 cm Stage Iv
  •  Left back 0.7 cm × 1.0 cm Stage II
  •  Left wrist   Healed ulcerClinical Interventions in Aging 2009:4 282
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Figure 4 Left foot, medical hallux, Stage III; Medial first metatarsal head, Stage II; Medial mid-foot, Stage II; Medial malleolus, Stage IV.
Figure 5 Posterior right thigh, Stage III.Clinical Interventions in Aging 2009:4 283
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Figure 6 Coccyx, Stage Iv.
Figure 7 Left hip, Stage Iv; unstageable eschar covered.Clinical Interventions in Aging 2009:4 284
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Figure 8 Lateral left ankle, Stage Iv; lateral mid-foot, unstageable.
Figure 9 Full body view, multiple ulcers.Clinical Interventions in Aging 2009:4 285
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Mr WC had not been wearing the protective devices at 
night and the ulcers worsened. The right heel ulcer measured 
6.5 cm × 5.5 cm with large amount yellow slough in center of 
the wound. Conservative sharp debridement was completed 
to decrease necrotic tissue and reduce bioburden. The left heel 
ulcer was clean, the wound base, a combination of slough and 
granulation tissue, measured 1.2 cm × 1.7 cm. The lesions 
were irrigated with NS and the initial dressing options were 
continued. At this time it was decided to begin negative 
pressure wound therapy to the right heel ulcer.
A VAC Freedom (Kinetic Concepts, Inc.) was applied 
with the unit set at 125 mmHg continuous negative pressure. 
In two weeks, the right heel ulcer measured 6.0 cm × 5.0 cm, 
the wound base was 80% granulation and 20% slough. The 
left heel ulcer measured 1.0 cm in diameter. Two weeks later, 
the right heel ulcer measured 5.5 cm × 4.5 cm × 1.0 cm, did 
not probe to bone and the wound base was fully granulated. 
The VAC dressing was discontinued and a foam dressing 
was applied with a light compression wrap to secure it. The 
foam dressing provided absorption and cushioning of the 
wound, compression controlled edema.
With the improvement in the wound, the decision was 
made to apply Dermagraft dressings to facilitate wound closure. 
Dermagraft was applied once a week for five weeks with contin-
ued attention to the control of exudate and edema. The ulcer on the 
left heel progressed to complete closure with conservative dress-
ing applications and continued pressure relief. The right heel also 
progressed to complete closure with application of Dermagraft 
combined with other conservative dressing techniques to con-
trol for infection through use of topical antimicrobials (silver 
alginates, Iodosorb gel), exudate management (foam and com-
posite dressings) and edema reduction with light compression 
wraps. Knee high compression stockings (20–30 mmHg) were 
used after healing was complete (Figures 10–12).
Figure 10 right posterior heel, Stage Iv, with slough and eschar.Clinical Interventions in Aging 2009:4 286
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Figure 11 right posterior heel with granulation tissue.
Figure 12 right posterior heel almost healed.Clinical Interventions in Aging 2009:4
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